-transparent.png){kind=logo}
Eleven patients with active proctitis or proctosigmoiditis completed one month's treatment with tripotassium dicitrato bismuthate enemas administered at night. Symptoms, sigmoidoscopic appearances, and the histological grade of acute inflammation were assessed at the commencement of therapy and after one month. An overall score of these features showed improvement in 9 of 11 patients, which encourages further investigation of bismuth in controlled trials for patients with inflammatory bowel disease.
Related Publications
E D Srivastava, and
G L Swift, and
S Wilkinson, and
G T Williams, and
B K Evans, and
J Rhodes
April 1988,
Gut,
E D Srivastava, and
G L Swift, and
S Wilkinson, and
G T Williams, and
B K Evans, and
J Rhodes
January 1986,
Postgraduate medical journal,
E D Srivastava, and
G L Swift, and
S Wilkinson, and
G T Williams, and
B K Evans, and
J Rhodes
February 1989,
Alimentary pharmacology & therapeutics,
E D Srivastava, and
G L Swift, and
S Wilkinson, and
G T Williams, and
B K Evans, and
J Rhodes
August 1989,
Alimentary pharmacology & therapeutics,
E D Srivastava, and
G L Swift, and
S Wilkinson, and
G T Williams, and
B K Evans, and
J Rhodes
March 1985,
The New Zealand medical journal,
E D Srivastava, and
G L Swift, and
S Wilkinson, and
G T Williams, and
B K Evans, and
J Rhodes
October 1991,
Alimentary pharmacology & therapeutics,
E D Srivastava, and
G L Swift, and
S Wilkinson, and
G T Williams, and
B K Evans, and
J Rhodes
August 1994,
Alimentary pharmacology & therapeutics,
E D Srivastava, and
G L Swift, and
S Wilkinson, and
G T Williams, and
B K Evans, and
J Rhodes
July 1985,
Schweizerische medizinische Wochenschrift,
E D Srivastava, and
G L Swift, and
S Wilkinson, and
G T Williams, and
B K Evans, and
J Rhodes
February 1989,
Alimentary pharmacology & therapeutics,
E D Srivastava, and
G L Swift, and
S Wilkinson, and
G T Williams, and
B K Evans, and
J Rhodes
July 1982,
Gut,
